RT Journal Article
SR Electronic
T1 Transmission routes of SARS-CoV-2 among healthcare workers of a French university hospital in Paris, France: a case-control study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.30.20223081
DO 10.1101/2020.10.30.20223081
A1 Contejean, Adrien
A1 Leporrier, Jérémie
A1 Canouï, Etienne
A1 Fourgeaud, Jacques
A1 Mariaggi, Alice-Andrée
A1 Alby-Laurent, Fanny
A1 Lafont, Emmanuel
A1 Beaudeau, Lauren
A1 Rouzaud, Claire
A1 Lecieux, Fabienne
A1 Greffet, Agnès
A1 L’Honneur, Anne-Sophie
A1 Tréluyer, Jean-Marc
A1 Lanternier, Fanny
A1 Casetta, Anne
A1 Frange, Pierre
A1 Leruez-Ville, Marianne
A1 Rozenberg, Flore
A1 Lortholary, Olivier
A1 Kernéis, Solen
YR 2020
UL http://medrxiv.org/content/early/2020/11/03/2020.10.30.20223081.abstract
AB In this case-control study on 564 healthcare workers of a university hospital in Paris (France), contacts without protection with COVID-19 patients or with colleagues were associated with infection with SARS-CoV-2, while working in a COVID-dedicated unit, using public transportation and having children kept in childcare facilities were not.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding has been received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethical Review Committee for publications of the Cochin university Hospital (CLEP) (N: AAA-2020-08012).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred in the manuscript are available.